Increased antidepressant sensitivity after prefrontal cortex glucocorticoid receptor gene deletion in mice

Physiology and Behavior

Volumn 138, Issue , 2015, Pages 113-117

  Hussain, Rifat J ^a   Jacobson, Lauren ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Corticosterone; Forced swim; Glucocorticoid receptor; Imipramine; Prefrontal cortex; Stress

Indexed keywords

CORTICOSTERONE; CRE RECOMBINASE; GLUCOCORTICOID RECEPTOR; GREEN FLUORESCENT PROTEIN; IMIPRAMINE; PARVOVIRUS VECTOR; ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CINGULATE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DEPRESSION LIKE IMMOBILITY; DRUG SENSITIVITY; FORCED SWIM TEST; GENE DELETION; GENE SILENCING; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILITY; INFRALIMBIC PREFRONTAL CORTEX; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRELIMBIC PREFRONTAL CORTEX; ANIMAL; BLOOD; C57BL MOUSE; DEFICIENCY; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOHISTOCHEMISTRY; MENTAL STRESS; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SWIMMING; TRANSGENIC MOUSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMIPRAMINE; IMMUNOHISTOCHEMISTRY; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84909956813     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.10.019     Document Type: Article

References (42)

1. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011, 36:183-206.
2. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
3. Duric V., Duman R.S. Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci 2013, 70:39-53.
4. Jacobson L. The hypothalamic-pituitary-adrenocortical axis: Neuropsychiatric aspects. Compr Physiol 2014, 4:715-738.
5. Cerqueira J.J., Pêgo J.M., Taipa R., Bessa J.M., Almeida O.F., Sousa N. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci 2005, 25:7792-7800.
6. Heydendael W., Jacobson L. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response. Brain Res 2008, 1238:93-107.
7. Heydendael W., Jacobson L. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice. Eur J Neurosci 2010, 31:892-902.
8. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993, 13:3839-3847.
9. Radley J.J., Gosselink K.L., Sawchenko P.E. A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J Neurosci 2009, 29:7330-7340.
10. Akana S.F., Chu A., Soriano L., Dallman M.F. Corticosterone exerts site-specific and state-dependent effects in the prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat depots. J Neuroendocrinol 2001, 13:625-637.
11. McKlveen J.M., Myers B., Flak J.N., Bundzikova J., Solomon M.B., Seroogy K.B., et al. Role of prefrontal cortex glucocorticoid receptors in stress and emotion. Biol Psychiatry 2013, 74:672-679.
12. Webster M.J., Knable M.B., O'Grady J., Orthmann J., Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 2002, 7:985-994.
13. Barsegyan A., Mackenzie S.M., Kurose B.D., McGaugh J.L., Roozendaal B. Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism. Proc Natl Acad Sci U S A 2010, 107:16655-16660.
14. de Quervain D.J., Aerni A., Schelling G., Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Front Neuroendocrinol 2009, 30:358-370.
15. Gourley S.L., Swanson A.M., Koleske A.J. Corticosteroid-induced neural remodeling predicts behavioral vulnerability and resilience. J Neurosci 2013, 33:3107-3112.
16. Institute of Laboratory Animal Resources Commissionon Life Sciences National Research Council. Guide for the care and use of laboratory animals 2010, National Academies Press, Washington, DC.
17. Brewer J.A., Khor B., Vogt S.K., Muglia L.M., Fujiwara H., Haegele K.E., et al. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nat Med 2003, 9:1318-1322.
18. Blaha M.L.L. Effects of indomethacin and buprenorphine analgesia on postoperative recovery of mice. J Am Assoc Lab Anim Sci 2008, 47:8-19.
19. Mitchell J.B., Meaney M.J. Effects of corticosterone on response consolidation and retrieval in the forced swim test. Behav Neurosci 1991, 105:798-803.
20. Veldhuis H.D., De Korte C.C.M.M., De Kloet E.R. Glucocorticoids facilitate the retention of acquired immobility during forced swimming. Eur J Pharmacol 1985, 115:211-217.
21. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
22. Gao G.P., Sena-Esteves M. Introducing genes into mammalian cells: viral vectors. Molecular Cloning: A Laboratory Manual 2012, 1209-1313. Cold Spring Harbor Laboratory Press, New York.
23. Kier A., Han J., Jacobson L. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. Endocrinology 2005, 146:1338-1347.
24. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 2007, Academic Press, San Diego, CA USA. 3rd ed.
25. Mukherjee K., Knisely A., Jacobson L. Partial glucocorticoid agonist-like effects of imipramine on hypothalamic-pituitary-adrenocortical activity, thymus weight, and hippocampal glucocorticoid receptors in male C57BL/6 mice. Endocrinology 2004, 145:4185-4191.
26. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci U S A 2005, 102:473-478.
27. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001, 49:391-404.
28. Hamani C., Diwan M., Isabella S., Lozano A.M., Nobrega J.N. Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. J Psychiatr Res 2010, 44:683-687.
29. Gabbott P.L., Warner T.A., Jays P.R., Salway P., Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol 2005, 492:145-177.
30. Miner L.H., Schroeter S., Blakely R.D., Sesack S.R. Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J Comp Neurol 2000, 427:220-234.
31. Schroeter S., Apparsundaram S., Wiley R.G., Miner L.H., Sesack S.R., Blakely R.D. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 2000, 420:211-232.
32. Jupp B., Caprioli D., Saigal N., Reverte I., Shrestha S., Cumming P., et al. Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex. Eur J Neurosci 2013, 37:1519-1528.
33. Solich J., Faron-Gorecka A., Kusmider M., Palach P., Gaska M., Dziedzicka-Wasylewska M. Norepinephrine transporter (NET) knock-out upregulates dopamine and serotonin transporters in the mouse brain. Neurochem Int 2011, 59:185-191.
34. Bhardwaj S.K., Quirion R., Srivastava L.K. Post-pubertal adrenergic changes in rats with neonatal lesions of the ventral hippocampus. Neuropharmacology 2004, 46:85-94.
35. O'Donnell J.M., Shelton R.C. Drug therapy of depression and anxiety disorders. Goodman and Gilman's The Pharmacological Basis of Therapeutics 2011, 429-459. Chapter 15, McGraw-Hill, New York.
36. Muigg P., Hoelzl U., Palfrader K., Neumann I., Wigger A., Landgraf R., et al. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry 2007, 61:782-796.
37. Duncan G.E., Knapp D.J., Johnson K., Breese G.R. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. J Pharmacol Exp Ther 1996, 277:1076-1089.
38. Vertes R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 2004, 51:32-58.
39. Malin E.L., Ibrahim D.Y., Tu J.W., McGaugh J.L. Involvement of the rostral anterior cingulate cortex in consolidation of inhibitory avoidance memory: interaction with the basolateral amygdala. Neurobiol Learn Mem 2007, 87:295-302.
40. Nestler E.J., Carlezon J.W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59:1151-1159.
41. Maier S.F., Watkins L.R. Role of the medial prefrontal cortex in coping and resilience. Brain Res 2010, 1355:52-60.
42. Sierra-Mercado D., Padilla-Coreano N., Quirk G.J. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011, 36:529-538.